Silence Therapeutics (SLN) Payables: 2019-2025
Historic Payables for Silence Therapeutics (SLN) over the last 1 years, with Sep 2025 value amounting to $17.0 million.
- Silence Therapeutics' Payables was N/A to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.5 million, marking a year-over-year change of. This contributed to the annual value of $16.4 million for FY2024, which is 5.55% up from last year.
- As of Q3 2025, Silence Therapeutics' Payables stood at $17.0 million, which was up 18.74% from $14.3 million recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' Payables peaked at $18.8 million during Q1 2025, and registered a low of $14.3 million during Q2 2025.
- Moreover, its 3-year median value for Payables was $16.4 million (2024), whereas its average is $16.4 million.
- Data for Silence Therapeutics' Payables shows a peak YoY spiked of 34.38% (in 2021) over the last 5 years.
- Over the past 5 years, Silence Therapeutics' Payables (Quarterly) stood at $14.5 million in 2021, then grew by 1.94% to $14.8 million in 2022, then climbed by 4.86% to $15.5 million in 2023, then grew by 5.55% to $16.4 million in 2024, then reached $17.0 million in 2025.
- Its last three reported values are $17.0 million in Q3 2025, $14.3 million for Q2 2025, and $18.8 million during Q1 2025.